SPOP acts a key regulatory hub in kidney cancer by degrading several tumor suppressors, including PTEN, which exhibits low levels in ccRCC patient samples, and SPOP-mediated degradation of PTEN promotes tumor cell proliferation in A498 ccRCC cells5. This evidence concerns the gene PTEN and kidney cancer.